Dnase1L3 Regulates Inflammasome-Dependent Cytokine Secretion

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• Pediatric-onset systemic lupus erythematosus is linked to a lack of the endonuclease DNase1L3.
• Absence of DNase1L3 leads to uncleared DNA from apoptotic bodies, promoting anti-DNA antibody production.
• DNase1L3 deficiency delays general immune activation and autoantibody responses.

Purpose of the Study:

• To investigate if DNase1L3 regulates immune activation, specifically inflammasome activation.
• To elucidate the mechanism by which DNase1L3 influences inflammasome pathways.

Main Methods:

• Studied DNase1L3 deficient mice (Dnase1L3-/-).
• Inhibited DNase1L3 activity.
• Measured inflammasome activation markers, including IL-1β release, pyroptosis (propidium iodide uptake, LDH release), and ASC speck formation.
• Assessed the role of DNase1L3 in ASC nuclear export.

Main Results:

• DNase1L3 inhibition blocked NLR family, pyrin domain containing 3 (NLRP3) and NLRC4 inflammasome-mediated release of high-mobility group box 1 protein and IL-1β.
• DNase1L3 inhibition only mildly impaired NLRP3-dependent pyroptosis.
• DNase1L3 is required for apoptosis-associated speck-like protein containing a caspase activation and recruitment domain (ASC) nuclear export and speck formation.
• DNase1L3 inhibition separated cytokine secretion from pyroptosis by targeting ASC.

Conclusions:

• DNase1L3 is essential for cytokine secretion downstream of inflammasome activation.
• DNase1L3 plays a critical role in regulating inflammasome-mediated immune responses.
• Targeting DNase1L3 may offer a therapeutic strategy for autoimmune diseases by modulating inflammasome activity.